Inhibition of CKLF1 ameliorates hepatic ischemia-reperfusion injury via MAPK pathway

CKLF1 Enhances Inflammation-mediated Carcinogenesis and Prevents Doxorubicin-induced Apoptosis via IL-6/STAT3 Signaling in HCC

(2019) Fan Zhu et al.   CLINICAL CANCER RESEARCH

CKLF1 Aggravates Focal Cerebral Ischemia Injury at Early Stage Partly by Modulating Microglia/Macrophage Toward M1 Polarization Through CCR4

(2019) Chen Chen et al.   CELLULAR AND MOLECULAR NEUROBIOLOGY

Progress in pharmacological research of chemokine like factor 1 (CKLF1)

(2018) Dan-Dan Liu et al.   CYTOKINE

CAAT/enhancer binding protein-homologous protein deficiency attenuates liver ischemia/reperfusion injury in mice

(2018) Seidai Wada et al.   LIVER TRANSPLANTATION

Intravital Microscopic Evaluation of the Effects of a CXCR2 Antagonist in a Model of Liver Ischemia Reperfusion Injury in Mice

(2018) Thiago Henrique Caldeira de Oliveira et al.   Frontiers in Immunology

Schisantherin A protects against liver ischemia-reperfusion injury via inhibition of mitogen-activated protein kinase pathway

(2017) Nanxin Zheng et al.   INTERNATIONAL IMMUNOPHARMACOLOGY

Brg1-mediated Nrf2/HO-1 pathway activation alleviates hepatic ischemia–reperfusion injury

(2017) Mian Ge et al.   Cell Death & Disease

The triterpenoid CDDO-imidazolide ameliorates mouse liver ischemia-reperfusion injury through activating the Nrf2/HO-1 pathway enhanced autophagy

(2017) Dongwei Xu et al.   Cell Death & Disease

The liver protection of propylene glycol alginate sodium sulfate preconditioning against ischemia reperfusion injury: focusing MAPK pathway activity

(2017) Shizan Xu et al.   Scientific Reports

C-C Chemokine Ligand-5 is critical for facilitating macrophage infiltration in the early phase of liver ischemia/reperfusion injury

(2017) Chiou-Mei Lee et al.   Scientific Reports

C19, a C-terminal peptide of CKLF1, decreases inflammation and proliferation of dermal capillaries in psoriasis

(2017) Yi Zheng et al.   Scientific Reports

CCL2–CCR2 signaling promotes hepatic ischemia/reperfusion injury

(2016) Junbin Zhang et al.   JOURNAL OF SURGICAL RESEARCH

Inhibition of chemokine-like factor 1 improves blood-brain barrier dysfunction in rats following focal cerebral ischemia

(2016) Ling-Lei Kong et al.   NEUROSCIENCE LETTERS

Inhibition of chemokine-like factor 1 protects against focal cerebral ischemia through the promotion of energy metabolism and anti-apoptotic effect

(2014) Ling Lei Kong et al.   NEUROCHEMISTRY INTERNATIONAL

Alleviation of murine allergic rhinitis by C19, a C-terminal peptide of chemokine-like factor 1 (CKLF1)

(2011) Yi Zheng et al.   INTERNATIONAL IMMUNOPHARMACOLOGY

Expression of chemokine-like factor 1 after focal cerebral ischemia in the rat

(2011) Ling-Lei Kong et al.   NEUROSCIENCE LETTERS

C19, a C-terminal peptide of chemokine-like factor 1, protects the brain against focal brain ischemia in rats

(2011) Ling-Lei Kong et al.   NEUROSCIENCE LETTERS

Hepatocyte signaling through CXC chemokine receptor-2 is detrimental to liver recovery after ischemia/reperfusion in mice

(2008) Satoshi Kuboki et al.   HEPATOLOGY

Two C-terminal peptides of human CKLF1 interact with the chemokine receptor CCR4

(2007) Ying Wang et al.   INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY